Publicacións (61) Publicacións de JOSE EMILIO SANCHEZ ALVAREZ

2023

  1. Etiopathogenesis of chronic kidney disease-associated pruritus: putting the pieces of the puzzle together

    Nefrologia, Vol. 43, Núm. 1, pp. 48-62

  2. Impact of peritoneal dialysis strategy on technique and patient survival

    Clinical Kidney Journal, Vol. 16, Núm. 12, pp. 2523-2529

  3. Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry

    Nefrologia, Vol. 43, Núm. 4, pp. 442-451

  4. Outcomes of COVID-19 in peritoneal dialysis patients: A report by the European Renal Association COVID-19 Database

    Peritoneal Dialysis International, Vol. 43, Núm. 1, pp. 23-36

  5. Perception of Spanish nephrologists on an old unsolved problem: Pruritus associated with chronic kidney disease (CKD-aP)

    Nefrologia, Vol. 43, Núm. 1, pp. 102-110

  6. Preparing European Nephrology for the next pandemic: Lessons from the ERACODA collaboration

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 3, pp. 575-582

2022

  1. Changing trends in presentation and indications of biopsy in lupus nephritis: Data from the Spanish Registry of Glomerulonephritis

    Clinical Kidney Journal, Vol. 15, Núm. 4, pp. 703-708

  2. Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: The Spanish COVID-19 KRT Registry

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1685-1697

  3. Hepatotoxicity induced by tolvaptan: A case report

    Nefrologia

  4. Kidneys also speak Spanish: Initiatives towards standardisation of our nephrology nomenclature

    Nefrologia, Vol. 42, Núm. 3, pp. 223-232

  5. Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings

    Kidney International Reports

2021

  1. COVID-19 vaccination among Spanish nephrologists: Acceptance and side effects

    Journal of Healthcare Quality Research, Vol. 36, Núm. 6, pp. 363-369

  2. ERACODA: The European database collecting clinical information of patients on kidney replacement therapy with COVID-19

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 12, pp. 2023-2025

  3. Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study

    Nefrologia, Vol. 41, Núm. 1, pp. 45-52

  4. Erratum: COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration (Nephrology Dialysis Transplantation (2020) 35:11 (1973-1983) DOI: 10.1093/ndt/gfaa261)

    Nephrology Dialysis Transplantation

  5. Global Dialysis Perspective: Spain

    Kidney360, Vol. 2, Núm. 2, pp. 344-349

  6. On the need to harmonize nephrological terminology in Ibero-American countries

    Nefrologia

  7. Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines

    Nefrologia, Vol. 41, Núm. 4, pp. 412-416

  8. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry

    American Journal of Transplantation, Vol. 21, Núm. 7, pp. 2573-2582

  9. Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: The VELREAL multicentre study

    Clinical Kidney Journal, Vol. 14, Núm. 2, pp. 681-687